1
004 Letters in Drug Design & Discovery, 2019, Vol. 16, No. 9
Kumar et al.
[
40]
Zhang, X.M.; Qiu, M.; Sun, J.; Zhang, Y.B.; Yang, Y.S.; Wang,
X.L; Zhu, H.L. Synthesis biological evaluation, and molecular
docking studies of 1,3,4-oxadiazole derivatives possessing 1,4-
benzodioxan moiety as potential anticancer agents. Bioorg. Med.
Chem., 2011, 19, 6518-6524.
Miller, T.A.; Witter, D.J.; Belvedere, S. Histone deacetylase
inhibitors. Med. Chem., 2003, 46, 5097-5116.
Sun, J., Li, M.H.; Qian, S.S.; Guo, F.J.; Dang, X.F.; Wang, X.M.;
Xue, Y.R.; Zhu, H.L. Synthesis and antitumor activity of 1,3,4-
oxadiazole possessing 1,4-benzodioxan moiety as a novel class
of potent methionine aminopeptidase type II inhibitors. Bioorg.
Med. Chem. Letters., 2013, 23, 2876-2879.
Liu, F.; Luo, X.Q.; Song, B.A.; Bhadury, P.S.; Yang, S.; Jin,
L.H.; Xue, W.; Hu, D.Y. Synthesis and antifungal activity of
novel sulfoxide derivatives containing trimethoxyphenyl
substituted 1,3,4-thiadiazole and 1,3,4-oxadiazole moiety.
Bioorg. Med. Chem. Lett., 2008, 16, 3632-3640.
[55]
Kumar, A.; D’Souza, S.S.; Nagaraj, S.R.M.; Gaonkar, S.L.;
Salimath, B.P.; Rai, L.K.M. Anti-angiogenic and anti-
proliferative effects of substituted-1,3,4-oxadiazole deriva-
tives is mediated by down regulation of VEGF and inhibition
of translocation of HIF-1in Ehrlich ascites tumor cells. Can-
cer Chemother. Pharmacol., 2009, 64, 1221-1233.ꢀ
El-Din, G.M.M.; El-Gamal, M.I.; Abdel-Maksoud, M.S.;
Hoyoo, K.; Oh, C.H. Synthesis and in vitro antiproliferative
activity of new 1,3,4-oxadiazole derivatives possessing
sulfonamide moiety. Eur. J. Med. Chem., 2015, 90, 45-52.
Jin, L.; Chen, J.; Song, B.; Chen, Z.; Yang, S.; Li, Q.; Hu,
D.; Xu, R. Synthesis, structure and bioactivity of N'-
substituted benzylidine-3,4,5-trimethoxy benzohydrazide and
3-acetyl-2-substituted phenyl-5 (3,4,5-trimethoxyphenyl)-
2,3-dihydro-1,3,4-oxadiazole derivatives. Bioorg. Med.
Chem. Lett., 2006, 16, 5036-5040.ꢀ
Sing, P.; Sharma, P.K.; Sharma, J.K.; Upadhyay, A.; Kumar,
N. Synthesis and evaluation of substituted diphenyl-1,3,4-
oxadiazole derivatives for central nervous system depressant
activit. Org. Med. Chem. Lett., 2012, 2, 8.
Tantray, M.A.; Khan, I.; Hamid, H.; Alam, M. S.; Dhulap,
A.; Kalam, A. Synthesis of benzimidazole-linked-1,3,4-
oxadiazole carboxamides as GSK-3b inhibitors with in vivo
antidepressant activit. Bioorg. Chem., 2018, 77, 393-401.
Ergun, Y.; Orhan, F.O.; Ozer, U.G.; Gisi, G. Synergistic effect of
[1H- [1,2,4] oxadiazole [4,3- a] quinoxalin-1-one] and
antidepressant drug in the mouse forced swimming test: possible
involvement of serotonergic pathway. Eur. J. Pharmacol., 2010,
630, 74-78.
Harfenist, M.; Heuser, D.J.; Joyner, C.T.; Batchelor, J.F.; White,
H.L. Selective inhibitors of monoamine oxidase 3 Structure-
activity relationship of tricyclics bearing imidazoline,
oxadiazole, or tetrazole groups. J. Med. Chem., 1996, 39, 1857-
1863.
Mayer, J.P.; Lewis, G.S.; McGee, C.; Bankaitis-Davis, D. Solid-
phase synthesis of benzimidazoles. Tetrahedron Lett., 1998, 39,
6655-6658.
Shruthi, N.; Boja P.; Vasantha K.; Mumtaz M.H.; Vaishali M.R.;
Vinitha R.P.; Mahima B.; Revannasiddppa B.C. Novel benzim-
idazole-oxadiazole hybrid molecules as promising antimicrobial
agents. RSC Adv., 2016, 6, 8303-8316.
[
[
41]
42]
[56]
[57]
[
43]
[58]
[59]
[60]
[
[
[
44]
45]
46]
Xu, W.M.; Han, F.F.; He, M.; Hu, D.Y.; He, J.; Yang, S.; Song,
B.A. Inhibition of tobaccobacterial wilt with sulfone derivatives
containing an 1,3,4-oxadiazole moiety. J. Agric. Food. Chem.,
2
012, 60, 1036-1041.ꢀ
Palaska, E.; Sahin, G.; Kelicen, P.; Durlu, N.T.; Altinok, G.
Synthesis and anti-inflammatory activity of 1-
acylthiosemicarbazides, 1,3,4-oxadiazoles, 1,3,4-thiadiazoles and
1
,2,4-triazole-3-thiones. II Farmaco., 2002, 57, 101-107.ꢀ
Jakubkiene, V.; Burbuliene, M.M.; Mekuskiene, G.; Udrenaite,
E.; Gaidelis, P.; Vainilavicius, P. Synthesis and anti-
inflammatory activity of 5-(6-methyl-2-substituted 4-
pyrimidinyloxymethyl)-1,3,4-oxadiazole-2-thiones and their
3
3
-morpholinomethyl derivatives. Il Farmaco., 2003, 58, 323-
28.
[61]
[
47]
Abd-Ellah, H.S.; Abdel-Aziz, M.; Shoman, M.E.; Beshr,
E.A.M.; Kaoud, T.S.; Ahmed, A.F.F. New 1,3,4-
oxadiazole/oxime
hybrids:
Design,
synthesis,
antiinflammatory, COX inhibitory activities and ulcerogenic
[62]
[63]
liability. Bioorg. Chem., 2017, 74, 15-29.
[
[
48]
49]
Palaska, E.; Sahin, G.; Kelicen, P.; Durlu, N.T.; Altinok, G.
Synthesis and antimicrobial activity of some 1,3,4-
oxadiazole derivatives. Farmaco., 2002, 57, 539-542.ꢀ
Rane, R.A.; Bangalore, P.K.; Borhade, S.D.; Khandare, P.K.
Synthesis and evaluation of novel 4-nitropyrrole-based 1,3,4-
oxadiazole derivatives as antimicrobial and anti-tubercular
agents. Eur. J. Med. Chem., 2013, 70, 49-58.ꢀ
[64]
[65]
[66]
Riss, T.L.; Moravec, R.A.; Niles, A.L.; Benink, H.A.; Worzella,
T.J.; Minor, L. Cell viability assays. In: Sittampalam GS G-EN,
Arkin, M.; Auld, D.; Austin, C.; Beejeek, B. editors. Assay
Guidance Manual. Bethesda (MD), USA: Eli Lilly & Co and
National Centre for Advancing Translational Sciences., 2012.
Mohan, N.R.; Sreenivasa, S.; Manojkumar, K.E.; Rao, M.C.T.;
Thippeswam, B.S.; Parameshwar, A.; Suchetana. Synthesis,
Antibacterial, anthelmintic and anti-inflammatory studies of
novel methylpyrimidinesulfonyl piperazine derivatives. J. Braz.
Chem. Soc., 2014, 25, 1012-1020.
Mohan, N.R.; Sreenivasa, S.; Manoj Kumar, K.E.; Anitha, H.C.;
Rao M.C.T.; Thippeswamy, B.S.; Gowda, V.K. Synthesis, char-
acterization and in vitro antimicrobial study of series of 1-
((substituted aryl/alkyl) sulfonyl)-4-tosylpiperazines. Indo. Am.
J. Pharm., 2013, 3, 1513-1520.
[
50]
Martinez-Grau, M.A.; Valcarcel, I.C.G.; Early, J.V.; Gessner,
R.K.; de Melo, C.S.; de la Nava, E.M.M.; Korkegian, A.;
Ovechkina, Y.; Flint, L.; Gravelle, A.; Cramer, J.W.; Desai,
P.V.; Street, L.J.; Odingo, J.; Masquelin, T.; Chibale, K.;
Parish, T. Synthesis and biological evaluation of aryl-
oxadiazoles as inhibitors of Mycobacterium tuberculosis.
Bioorganic Med. Chem. Lett., 2018, 28, 1758-1764.
[
[
51]
52]
Ahsan, M.J.; Samy, J.G.; Khalilullah, H.; Nomani, M.S.;
Saraswat, P.; Singh, G.R. Molecular properties prediction
and synthesis of novel 1,3,4-oxadiazole analogues as potent
antimicrobial and antitubercular agents. Bioorg. Med. Chem.
Lett., 2011, 21, 7246-7250.ꢀ
Taha, M.; Rahim, F.; Imran, S.; Ismail, N.H.; Ullah, H.; Sel-
varaj, M.; Javid, M.T.; Salar, U.; Ali, M.; Khan, K.M. Syn-
thesis, a-glucosidase inhibitory activity and in silico study of
tris-indole hybrid scaffold with oxadiazole ring: As potential
leads for the management of type-II diabetes mellitus.
Bioorg. Chem., 2017, 74, 30-40.ꢀ
[67]
[68]
Lipinski, C.A.; Lombardo, F.; Dominy, B.W.; Feency, P.J. Adv.
Drug Deliv. Rev., 1997, 23, 3.
Lipinski, C.A.; Lombardo, F.; Dominy, B.W.; Feency, P.J. Adv.
Drug Deliv. Rev., 2001, 46, 3.
QikProp, version 3.5, Schrödinger, LLC, New York, NY, 2014
[
[
69]
70]
[
[
53]
54]
Nazira, M.; Abbasia, M.A.; Aziz-ur-Rehman.; Siddiqui, S.Z.;
Khan, K.M.; Kanwal.; Salar, U.; Shahid, M.; Ashraf, M.;
Lodhi, M.A.; Khane, F.A. New indole based hybrid
oxadiazole scaffolds with N-substituted acetamides: As
potent anti-diabetic agents. Bioorg. Chem., 2018, 81, 253-
Bernard, D.; Zhao, Y.; Wang, S. AM-8553: A Novel MDM2
inhibitor with
a promising outlook for potential clinical
development. J. Med. Chem., 2012, 55, 4934-4935.
Protein Preparation Wizard; Epik version 2.3, 2012; Schrödinger,
LLC, New York.
[
[
71]
72]
2
63
Jorgensen, W.L.; Maxwell, D.S.; Tirado-Rives, J. Development
and testing of the OPLS all-atom force field on conformational
energetics and properties of organic liquids. J. Am. Chem. Soc.,
Shingalapur, R.V.; Hosamani, K.M.; Keri, R.S.; Hugar, M.H.
Derivatives of benzimidazole pharmacophore: Synthesis,
anticonvulsant, antidiabetic and DNA cleavage studies. Eur.
J. Med. Chem., 2010, 45, 1753-1759.ꢀ
1
996, 118, 11225-11236.
[
[
73]
74]
LigPrep, version 3.1, Schrödinger, LLC, New York, NY, 2014.
Glide, version 3.3, Schrödinger, LLC, New York, NY, 2014.